GUILFORD, Conn., Sept. 09, 2020 (GLOBE NEWSWIRE) -- InveniAI ® LLC (InveniAI), a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform drug ...
Talus Bioscience, Inc. ("Talus Bio"), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRISM BioLab Co., Ltd. ("PRISM") to accelerate the discovery and ...
The acquisition aims to enhance HYTN’s manufacturing processes, and specifically to increasing the yield of tryptamine in psychedelic mushrooms, and grants HYTN exclusive access to Prism’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback